These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 37020110)
1. The evolution of SARS-CoV-2. Markov PV; Ghafari M; Beer M; Lythgoe K; Simmonds P; Stilianakis NI; Katzourakis A Nat Rev Microbiol; 2023 Jun; 21(6):361-379. PubMed ID: 37020110 [TBL] [Abstract][Full Text] [Related]
2. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment. Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691 [TBL] [Abstract][Full Text] [Related]
3. On the evolution of SARS-CoV-2 and the emergence of variants of concern. Magiorkinis G Trends Microbiol; 2023 Jan; 31(1):5-8. PubMed ID: 36344310 [TBL] [Abstract][Full Text] [Related]
4. SARS-COV-2 Variants: Differences and Potential of Immune Evasion. Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007 [TBL] [Abstract][Full Text] [Related]
5. Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis. Giovanetti M; Cella E; Ivanov I; Grigorova L; Stoikov I; Donchev D; Dimitrova R; Slavov SN; Mavian C; Fonseca V; Scarpa F; Borsetti A; Korsun N; Trifonova I; Dobrinov V; Kantardjiev T; Christova I; Ciccozzi M; Alexiev I Viruses; 2023 Sep; 15(9):. PubMed ID: 37766330 [TBL] [Abstract][Full Text] [Related]
6. Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy. Huang W; Yin C; Briley KP; Dalzell WAB; Fallon JT Viruses; 2023 Aug; 15(8):. PubMed ID: 37632101 [TBL] [Abstract][Full Text] [Related]
7. Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern. Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Aristokleous A; Christodoulou C; Gregoriou I; Ioannides M; Kalakouta O; Karagiannis C; Koumbaris G; Loizides C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Richter J; Schmitt M; Shammas C; Stylianou DC; Themistokleous G; The Comessar Network ; Lemey P; Kostrikis LG Viruses; 2022 Dec; 15(1):. PubMed ID: 36680148 [TBL] [Abstract][Full Text] [Related]
8. CD8 Kombe Kombe AJ; Biteghe FAN; Ndoutoume ZN; Jin T Front Immunol; 2022; 13():962079. PubMed ID: 36389664 [TBL] [Abstract][Full Text] [Related]
9. Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2. Giovanetti M; Branda F; Cella E; Scarpa F; Bazzani L; Ciccozzi A; Slavov SN; Benvenuto D; Sanna D; Casu M; Santos LA; Lai A; Zehender G; Caccuri F; Ianni A; Caruso A; Maroutti A; Pascarella S; Borsetti A; Ciccozzi M J Med Virol; 2023 Aug; 95(8):e29012. PubMed ID: 37548148 [TBL] [Abstract][Full Text] [Related]
10. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape. Bushman M; Kahn R; Taylor BP; Lipsitch M; Hanage WP Cell; 2021 Dec; 184(26):6229-6242.e18. PubMed ID: 34910927 [TBL] [Abstract][Full Text] [Related]
11. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion? Wang Z; Zhou M; Fu Z; Zhao L Front Immunol; 2021; 12():693579. PubMed ID: 34335604 [TBL] [Abstract][Full Text] [Related]
13. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic. Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226 [TBL] [Abstract][Full Text] [Related]
14. Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic. González-Vázquez LD; Arenas M Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833334 [TBL] [Abstract][Full Text] [Related]
15. [Genomics and epidemiology of SARS-CoV-2 lineage]. Sukegawa S; Takeuchi H Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991 [TBL] [Abstract][Full Text] [Related]
16. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil. Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035 [TBL] [Abstract][Full Text] [Related]
17. After the pandemic: perspectives on the future trajectory of COVID-19. Telenti A; Arvin A; Corey L; Corti D; Diamond MS; García-Sastre A; Garry RF; Holmes EC; Pang PS; Virgin HW Nature; 2021 Aug; 596(7873):495-504. PubMed ID: 34237771 [TBL] [Abstract][Full Text] [Related]
18. The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion. Zhan Y; Ye L; Ouyang Q; Yin J; Cui J; Liu K; Guo C; Zhang H; Zhai J; Zheng C; Guo A; Sun B J Med Virol; 2023 Sep; 95(9):e29113. PubMed ID: 37750416 [TBL] [Abstract][Full Text] [Related]
20. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC). Tyagi N; Sardar R; Gupta D PeerJ; 2022; 10():e13562. PubMed ID: 35765592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]